RARA CRAFT DATABASE for FDA Medical Devices
510(k)K192050

FDA DEVICE FACTS

ETEST Eravacycline (ERV) (0.002 – 32 µg/mL)

Biomerieux S.A.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 27, 2019PRODUCT CODEJWY

Indications for use

ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria. The system comprises a predefined antibiotic gradient which is used to determine the Minimum Inhibitory Concentration (MIC, i) of different antimicrobial agents against microorganisms tested on agar media using overnight incubation. Eravacycline has been shown to be active against most isolates of the microorganisms listed below according to the FDA label for this antimicrobial agent. ETEST® ERV can be used to determine the MIC of Eravacycline against the following microorganisms: Active both in vitro and in clinical infections: Gram-negative: Citrobacter freundii Enterobacter cloacae Escherichia coli Klebsiella oxytoca Klebsiella pneumoniae Gram-positive: Enterococcus faecalis Enterococcus faecium In vitro data are available for the following microorganisms, but clinical significance is unknown: Citrobacter koseri Klebsiella aerogenes

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026